103 related articles for article (PubMed ID: 11339853)
1. Downregulation of a tumor promotion immune response via induction of oral tolerance towards tumor-associated-antigens: can we 'eat the tumor'?
Gotsman I; Ilan Y
Med Hypotheses; 2001 Apr; 56(4):487-92. PubMed ID: 11339853
[TBL] [Abstract][Full Text] [Related]
2. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
3. Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.
Israeli E; Safadi R; Melhem A; Pappo O; Shibolet O; Klein A; Hemed N; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Liver Int; 2004 Aug; 24(4):295-307. PubMed ID: 15287852
[TBL] [Abstract][Full Text] [Related]
4. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.
Safadi R; Israeli E; Papo O; Shibolet O; Melhem A; Bloch A; Rowe M; Alper R; Klein A; Hemed N; Segol O; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Am J Gastroenterol; 2003 Nov; 98(11):2505-15. PubMed ID: 14638356
[TBL] [Abstract][Full Text] [Related]
6. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
7. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
8. Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice.
Gotsman I; Israeli D; Alper R; Rabbani E; Engelhardt D; Ilan Y
Int J Cancer; 2002 Jan; 97(1):52-7. PubMed ID: 11774243
[TBL] [Abstract][Full Text] [Related]
9. [Changes in the immune function of dendritic cells (DC) derived from HBV-related hepatocellular carcinoma (HCC) patient's peripheral blood monocytes (PBMC) pulsed with tumor antigen].
Wong YQ; Qiu SJ; Tang ZY; Ye SL; Liu YK; Fan J; Sun RX; Zhao Y
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):339-42. PubMed ID: 15918966
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
[TBL] [Abstract][Full Text] [Related]
11. Definition of tumor-associated antigens in hepatocellular carcinoma.
Stenner-Liewen F; Luo G; Sahin U; Tureci O; Koslovski M; Kautz I; Liewen H; Pfreundschuh M
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):285-90. PubMed ID: 10750667
[TBL] [Abstract][Full Text] [Related]
12. Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications.
Fatourou EM; Koskinas JS
Expert Rev Anticancer Ther; 2009 Oct; 9(10):1499-510. PubMed ID: 19828011
[TBL] [Abstract][Full Text] [Related]
13. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
[TBL] [Abstract][Full Text] [Related]
14. The immune response induced by hepatitis B virus principal antigens.
Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
[TBL] [Abstract][Full Text] [Related]
15. Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma.
Uemura M; Nouso K; Kobayashi Y; Tanaka H; Nakamura S; Higashi T; Ono T; Nakayama E; Hanafusa T; Shiratori Y
Cancer; 2003 May; 97(10):2474-9. PubMed ID: 12733146
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.
Zerbini A; Pilli M; Penna A; Pelosi G; Schianchi C; Molinari A; Schivazappa S; Zibera C; Fagnoni FF; Ferrari C; Missale G
Cancer Res; 2006 Jan; 66(2):1139-46. PubMed ID: 16424051
[TBL] [Abstract][Full Text] [Related]
17. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
[TBL] [Abstract][Full Text] [Related]
18. Identification of tumor-associated antigens in human hepatocellular carcinoma by autoantibodies.
Chen X; Fu S; Chen F; Chen H; Chen Z
Oncol Rep; 2008 Oct; 20(4):979-85. PubMed ID: 18813843
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.
Sun K; Wang L; Zhang Y
Cell Mol Immunol; 2006 Jun; 3(3):197-203. PubMed ID: 16893500
[TBL] [Abstract][Full Text] [Related]
20. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
Shang XY; Chen HS; Zhang HG; Pang XW; Qiao H; Peng JR; Qin LL; Fei R; Mei MH; Leng XS; Gnjatic S; Ritter G; Simpson AJ; Old LJ; Chen WF
Clin Cancer Res; 2004 Oct; 10(20):6946-55. PubMed ID: 15501973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]